MedPath

Aurobac Therapeutics SAS

🇫🇷France
Ownership
Joint Venture
Employees
-
Market Cap
-
Website
https://aurobac-tx.com

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Phase 1 Single Ascending Dose Study With ATX101

Not Applicable
Recruiting
Conditions
Healthy Participants
Interventions
Drug: Placebo
First Posted Date
2025-08-06
Last Posted Date
2025-08-14
Lead Sponsor
Aurobac Therapeutics SAS
Target Recruit Count
24
Registration Number
NCT07107802
Locations
🇵🇹

BlueClinical Phase I, Porto, Portugal

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.